In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020
The objective of this study was to assess the in vitro activity of ceftaroline and a panel of comparator agents against isolates causing skin and soft tissue infections (SSTIs) collected in Africa/Middle East, Asia–Pacific, Europe, and Latin America from 2019–2020. Minimum inhibitory concentrations...
Main Authors: | Alona Kuraieva, Guillermo Cabezas-Camarero, Pattarachai Kiratisin, Eric Utt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/8/1237 |
Similar Items
-
Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019
by: Eric Utt, et al.
Published: (2023-06-01) -
In Vitro Activity Of Ceftaroline And Comparators Against Staphylococcus aureus Isolates: Results From 6 Years Of The ATLAS Program (2012 To 2017)
by: Zhang Z, et al.
Published: (2019-10-01) -
Ceftaroline in the treatment of methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus bacteremia and infective endocarditis in end-stage renal disease
by: Kristen Fuhrmann, et al.
Published: (2013-09-01) -
Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
by: Harsha Sreedharan, et al.
Published: (2021-01-01) -
In vitro activity of ceftaroline: A novel antibiotic against methicillin-resistant Staphylococcus aureus
by: Vaishali Gaikwad, et al.
Published: (2016-01-01)